BioSpace News Archive

STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that it has completed the previously announced acquisition of Cantel Medical, a global provider of infection prevention products and services to endoscopy, dental, dialysis and life sciences Customers.

Zivo Bioscience, Inc. (NASDAQ: ZIVO, ZIVOW) (“ZIVO” and the “Company”), a biotech/agtech R&D company engaged in the development and commercialization of therapeutic, medicinal and nutritional product candidates originally derived from proprietary algal cultures, today announced the closing of its previously announced underwritten public offering of 2,760,000 units at a price to the public of $5.00 per unit.

This summer is blasting off with the FedEx St. Jude Angels & Stars Giving Campaign for St. Jude Children’s Research Hospital® from now through June 30, with an online auction going live on June 10.

SS&C Technologies Holdings, Inc. announced that financial institutions from multiple regulatory jurisdictions around the world are now implementing its Fundamental Review of the Trading Book solution in 2021.

Novartis today announced robust data from the primary analysis of the pivotal Phase II ELARA trial of Kymriah® (tisagenlecleucel) in patients with relapsed or refractory (r/r) follicular lymphoma (FL)1.

As part of the 2021 ASCO Annual Meeting, precision oncology company Lucence is sharing real-world data supporting clinical applications of its amplicon-based liquid biopsy assay.

PRESS RELEASE AB SCIENCE WILL HOST A LIVE WEBCAST ON THURSDAY JUNE 3, 2021 FOLLOWING THE VOLUNTARY HOLD IN THE CLINICAL STUDIES OF MASITINIB

Lixte Biotechnology Holdings, Inc. (Nasdaq: LIXT), a clinical-stage drug discovery company developing pharmacologically active drugs for use in cancer treatment, today announced the enrollment of the first patient in a Phase 1b clinical trial with City of Hope, a world-renowned independent cancer research and treatment center.

Crown Therapeutics, a division of Crown Laboratories, is proud to announce the launch of maximum strength Mineral Ice Foam, dermatologically tested and dermatologist approved.

3M and Pandemic Action Network will collaborate on programs to help stem the spread of COVID-19 and also announced a commitment to work together to help prepare for future pandemics.